Carreno, Flavia R.

Vagal nerve stimulation for treatment-resistant depression

Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics

Vagus Nerve Stimulation ResearchTreatment of Major Depression

Cited by 208

Activation of a ventral hippocampus–medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine

Carreno, F. R., Donegan, J. J., Boley, A. M., Shah, A., DeGuzman, M., Frazer, A., & Lodge, D. J. (2016) · Molecular Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 205

Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia

Perez, S. M., Carreno, F. R., Frazer, A., & Lodge, D. J. (2014) · Journal of Neuroscience

Vagus Nerve Stimulation ResearchSchizophrenia research and treatment

Cited by 65

The allure of transcutaneous vagus nerve stimulation as a novel therapeutic modality

Carreno, F. R., & Frazer, A. (2016) · Biological Psychiatry

Vagus Nerve Stimulation ResearchHeart Rate Variability and Autonomic Control

Cited by 34

Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects

Carreno, F. R., Collins, G. T., Frazer, A., & Lodge, D. J. (2017) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 31